Congenital heart disease: Difference between revisions
No edit summary |
No edit summary |
||
| Line 86: | Line 86: | ||
#Cyanosis (shunt) | #Cyanosis (shunt) | ||
##PGE1* (0.01mg/kg; may repeat at double dose x 3) | ##PGE1* (0.01mg/kg; may repeat at double dose x 3) | ||
## | ##Pressors | ||
##O2 only if inadequate tissue perfusion / SpO2 below baseline | |||
#Tet spells | #Tet spells | ||
## | ##Knee chest position | ||
###Incr venous return to heart, incr SVR (decr R>L shunting) | |||
##O2 | ##O2 | ||
##Morphine or NS to increase preload | |||
##Nabicarb 2mEq/kg IV bolus (promotes vasodilation) | |||
##Propranolol 0.2mg/kg IV (relieves infundibular spasm) | |||
##Phenylephrine 2-10mcg/kg/min to incr SVR | |||
#CHF | #CHF | ||
##diuretis, NTG, inotrops | ##diuretis, NTG, inotrops | ||
| Line 103: | Line 110: | ||
#Flushing | #Flushing | ||
<br/><br/><br/><br/> | <br/><br/><br/><br/><br/><br/> | ||
[[Category:Peds]] <br/>[[Category:Cards]] <br/><br/> | [[Category:Peds]] <br/>[[Category:Cards]] <br/> <br/> | ||
Revision as of 18:10, 22 June 2011
Background
- Cyanotic
- Tetralogy
- Tricuspid anomalies
- Truncus arteriosus
- Total anomalous pulmonary venous return
- Transposition
- Acyanotic
- VSD
- ASD
- PDA
- AV canal
- Pulmonary/aortic stenosis
Diagnosis
| Clinical Presentation | Causative Conditions in Neonates | Causative Conditions in Infants and Children |
|---|---|---|
| Cyanosis | Transposition of the great arteries, TOF, tricuspid atresia, truncus arteriosus, total anomalous pulmonary venous return | TOF, Eisenmenger complex |
| Cardiovascular shock | Critical AS, coarctation of the aorta, HLHS | Coarctation of the aorta (infants) |
| Congestive heart failure | Rare: PDA, HLHS | PDA, VSD, ASD, atrioventricular canal |
| Murmur | PDA, valvular defects (AS, PS) | VSD, ASD, PDA, outflow obstructions, valvular defects (AS, PS) |
| Syncope | — | AS, PS, Eisenmenger complex |
| Hypertension | — | Coarctation of the aorta |
| Arrhythmias | — | ASD, Ebstein anomaly, postsurgical complication after repair of congenital heart defect |
Work-Up
- CXR & ECG
| Cardiac Lesion | Chest Radiograph | ECG |
|---|---|---|
| Tetralogy of Fallot | Boot-shaped heart, normal-sized heart, decreased pulmonary vascular markings | Right axis deviation, right ventricular hypertrophy |
| Transposition of the great arteries | Egg-shaped heart, narrow mediastinum, increased pulmonary vascular marking | Right axis deviation, right ventricular hypertrophy |
| Total anomalous pulmonary venous return | Snowman sign, significant cardiomegaly, increased pulmonary vascular markings | Right axis deviation, right ventricular hypertrophy, right atrial enlargement |
| Tricuspid atresia | Heart of normal to slightly increased size, decreased pulmonary vascular markings | Superior QRS axis with right atrial hypertrophy, left atrial hypertrophy, left ventricular hypertrophy |
| Truncus arteriosus | Cardiomegaly, increased pulmonary vascular markings | Biventricular hypertrophy |
Treatment (by presentation)
- Cyanosis (shunt)
- PGE1* (0.01mg/kg; may repeat at double dose x 3)
- Pressors
- O2 only if inadequate tissue perfusion / SpO2 below baseline
- Tet spells
- Knee chest position
- Incr venous return to heart, incr SVR (decr R>L shunting)
- O2
- Morphine or NS to increase preload
- Nabicarb 2mEq/kg IV bolus (promotes vasodilation)
- Propranolol 0.2mg/kg IV (relieves infundibular spasm)
- Phenylephrine 2-10mcg/kg/min to incr SVR
- Knee chest position
- CHF
- diuretis, NTG, inotrops
- Shock (resrictive lesion)
- Dobutamine
PGE1 Side Effects
- Apnea (intubate)
- Hypotension
- Bradycardia
- Hyperexia
- Flushing
